For research use only. Not for therapeutic Use.
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].
| Catalog Number | I041569 |
| CAS Number | 1443004-16-7 |
| Purity | ≥95% |
| Reference | [1]. Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534. |
